Biobot Analytics

Biobot Analytics aims to revolutionize public health by converting wastewater infrastructure into sophisticated public health monitoring systems. Recognized by Fast Company as a leading innovator in 2021, Biobot Analytics employs technology developed at MIT to analyze sewage for biomarkers, providing insights into community health. Initially focused on addressing the opioid crisis, the company expanded its capabilities in 2020 to include COVID-19 tracking, estimating the prevalence and trends of the virus in numerous communities. Biobot Analytics has served nearly 500 communities across 43 U.S. states, delivering COVID-19 case estimates for over 13% of the U.S. population.

Beyond addressing immediate crises like the opioid epidemic and the COVID-19 pandemic, Biobot Analytics is dedicated to transforming sewage into a valuable data resource, constructing a comprehensive public health database. The long-term vision includes utilizing Biobot data as an early warning system for disease outbreaks, a tool for mapping nutritional disparities, and a resource for understanding various other public health challenges.